metricas
covid
Buscar en
Revista Colombiana de Reumatología (English Edition)
Toda la web
Inicio Revista Colombiana de Reumatología (English Edition) Comorbidity of sleep apnoea syndrome in patients with fibromyalgia in a sleep cl...
Información de la revista
Vol. 29. Núm. 3.
Páginas 177-181 (julio - septiembre 2022)
Visitas
770
Vol. 29. Núm. 3.
Páginas 177-181 (julio - septiembre 2022)
Original Investigation
Acceso a texto completo
Comorbidity of sleep apnoea syndrome in patients with fibromyalgia in a sleep clinic
Comorbilidad de síndrome de apnea del sueño en pacientes con fibromialgia en una clínica de sueño
Visitas
770
Renny Jaimes Beltrána,
Autor para correspondencia
, Javier Ramírez Figueroab, Natalia Andrea Skupin Ruedac
a Clínica Neumológica y del Sueño, Cúcuta, Colombia
b Bioreuma, Cúcuta, Colombia
c General Medicine, Clínica Neumológica y del Sueño, Cúcuta, Colombia
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Abstract
Introduction

Fibromyalgia syndrome (FMS) is characterized by chronic musculoskeletal pain, fatigue, and the sense of waking unrefreshed. Obstructive sleep apnoea syndrome (OSAS) and FMS have symptoms in common and the association of OSAS in these patients could confuse the diagnosis and worsen the severity and prognosis of FMS. The objective of this study was to establish the presence of OSAS in patients with FMS and sleep complaints in a sleep clinic.

Methods

A cross-sectional study was conducted in patients aged 18 and above with FMS who were referred by rheumatology to a sleep clinic to confirm OSAS with polysomnography from 2015 to 2018. Descriptive statistics tools were applied.

Results

Polysomnographic investigations were performed in 51 patients with FMS. OSAS was detected in 82% of patients. The mean age was 65 years. Of the patients studied, 82% were women and 78% of them had OSAS. All the male patients with FM had OSAS. Of the patients, 27.5% were normal weight and 45% were overweight. Of the patients, 23% had severe OSAS, 31% moderate and 45% mild.

Conclusion

We found a high frequency of OSAS in this group of FMS patients. Since the 2 diseases share symptoms, it is interesting to delve deeper into the investigation of common pathophysiological mechanisms. The coexistence of the 2 pathologies poses diagnostic and therapeutic challenges that implies the need for further study at local level.

Keywords:
Fibromyalgia
Sleep apnoea syndromes
Sleep obstructive apnoea
Sleep
Rheumatology
Resumen
Introducción

La fibromialgia (FM) se caracteriza por dolor crónico, cansancio y sueño no reparador. El síndrome de apnea hipopnea obstructiva del sueño (SAHOS) tiene síntomas en común con la FM y su presencia puede confundir el diagnóstico y empeorar la gravedad y el pronóstico de la FM. El objetivo de este estudio fue establecer la presencia de SAHOS en pacientes con FM y alteraciones del sueño en una clínica de sueño.

Métodos

Estudio observacional, de corte transversal, en pacientes mayores de 18 años con FM remitidos por Reumatología a una clínica de sueño para confirmar SAHOS por medio de polisomnografía, entre el 2015 y el 2018. Se aplicaron herramientas de estadística descriptiva.

Resultados

Se realizó polisomnografía completa a 51 pacientes con FM y se confirmó SAHOS en el 82%. La edad media fue de 65 años. El 82% de los pacientes estudiados fueron mujeres y, de estas, el 78% tuvo SAHOS. Al 100% de los hombres con FM se les diagnosticó SAHOS. El 27,5% tuvo un peso normal y el 45% sobrepeso. El 23% de los pacientes tuvo SAHOS grave, el 31% moderado y el 45% leve.

Conclusiones

Encontramos una alta frecuencia de SAHOS en este grupo de pacientes con FM. Las 2 enfermedades comparten síntomas, por lo que es interesante profundizar más en la investigación de mecanismos fisiopatológicos comunes. La coexistencia de las 2 patologías plantea retos diagnósticos y terapéuticos que vislumbran la necesidad de estudios más profundos a escala local.

Palabras clave:
Fibromialgia
Síndromes de la apnea del sueño
Apnea obstructiva del sueño
Sueño
Reumatología
Texto completo
Introduction

Fibromyalgia (FM) is a disease characterized by chronic diffuse musculoskeletal pain of non-articular origin, associated with unrefreshing sleep and fatigue. The proposed pathophysiological mechanism is based on central sensitization, sleep deficit, psychosocial stress, physical trauma, and genetic and endocrine factors.1–3

The worldwide prevalence of FM is 2-8% and women are most commonly affected.4 In Colombia, the estimated prevalence is 0.72%, with equal predominance in the female gender.5

The diagnosis of FM is clinical and, as there is no confirmatory test, is based on the symptoms reported by the patients and on the exclusion of other diseases.6,7

In 2011, the American College of Rheumatology recommended that, in addition to evaluating pain as the main symptom, other types of symptoms, such as those related to sleep, fatigue, cognitive difficulties and other somatic symptoms, should be studied in greater depth to establish the diagnosis of FM.8,9

In the general population, the most frequent sleep disorders are insomnia and obstructive sleep apnea hypopnea syndrome (OSAHS). In patients who suffer from FM and OSAHS at the same time, unrefreshing sleep and generalized pain are common. İnönü et al. evidenced a prevalence of OSAHS of 50% (n = 12) in patients with FM and sleep disturbances.10

Some authors associate insomnia and OSAHS with chronic widespread pain and propose sleep deprivation and apnea as causes of pain syndromes in patients with rheumatic disease.11–14 Indeed, in relation to the treatment of both diseases, Marvisi et al. studied the effect of CPAP on the mitigation of FM symptoms in patients with FM and OSAHS.15

One hypothesis that may explain the relationship between sleep apnea and FM is the alteration of sleep slow waves. The reduction of sleep slow waves is associated with worsening of pain and increased central sensitization to both painful and non-painful stimuli. In OSAHS, these waves are altered, which could be one of the pathophysiological keys to link this syndrome with the increase in generalized pain typical of FM.16

No studies on the comorbidity of OSAHS in patients with FM in Colombia are known. Considering the possible repercussions of having both diseases, we sought to characterize and measure the presence of OSAHS in a group of patients with FM and sleep disorders, referred from a rheumatology clinic to a sleep clinic.

Methods

A descriptive observational cross-sectional study was developed. Information was collected from all patients referred by Rheumatology with a diagnosis of FM and sleep complaints to a sleep clinic in the city of Cucuta (Colombia) between January 1, 2015 and August 1, 2018.

Rheumatology established the diagnosis of FM in a rheumatology center, according to the modified criteria of the American College of Rheumatology.8 Then, the presence of symptoms related to sleep was inquired about and those who had FM and sleep complaints, such as insomnia or fragmented sleep were referred to Pneumology.

Pneumology assessed all the patients and requested a complete baseline polysomnography to confirm or rule out OSAHS.

The apnea hypopnea index (AHI) was calculated by the number of episodes of apnea plus hypopnea per hour of sleep. The patients with AHI ≥ 5 events/h were diagnosed with OSAHS, whereas those with AHI between 5 and 15 were classified as mild and those who had between 15 and 30 events per hour as moderate; those who had AHI > 30 were considered severe, according to the criteria of the American Association of Sleep Medicine.17

The inclusion criteria were:

  • Being 18 years of age or older.

  • Having been referred by Rheumatology with a confirmed diagnosis of fibromyalgia and some sleep complaint.

  • Having a polysomnographic record.

The study was approved by the Ethics Committee of the Clínica Neumológica y del Sueño.

Prior to the baseline polysomnography, data were collected according to institutional protocol, related to weight, height, gender, age, Epworth scale, and neck circumference.

The baseline polysomnographies were performed at the Clínica Neumológica y del Sueño with Alice 6 LDE and SleepVirtual BWII PSG polysomnographs according to the criteria of the American Association of Sleep Medicine with simultaneous measurement of electroencephalography, electrooculogram, submental and anterior tibial electromyography, electrocardiography, body position sensor, microphone for snoring, thoracic and abdominal movement, nasal cannula for flow measurement and pulse oximetry.

Data analysis

The quantitative variables were presented as arithmetic means ± standard deviations and the rest of the qualitative variables as numbers and their percentages.

Results

Of the 73 patients referred by Rheumatology with a diagnosis of FM, 51 underwent baseline polysomnography and were included in the study. The rest were excluded because they did not attend the exam.

The mean age of the sample was 65.14 ± 17.63 years. 82% of the patients studied were women and, of them, 78% had OSAHS. All men referred with fibromyalgia had associated OSAHS. 27.5% of the patients had a normal body mass index and 45% were overweight (Table 1).

Table 1.

Sociodemographic and clinical characteristics of patients diagnosed with fibromyalgia at the Clínica Neumológica y del Sueño, years 2015-2018.

Variable     
  Mean  SD 
Age  65.14  17.63 
  Number 
Gender
Female  42  82.35 
Male  17.65 
BMI (kg/m2)
<18.5: underweight 
18.5-24.9: normal  14  27.50 
25-29.9: overweight  23  45 
≥30 obesity  14  27.50 
Presence of OSAHS
Present  42  82.4 
Absent  17.6 
Epworth sleepiness scale
0-9 points  28  54.9 
10-24 points  23  41.5 
Neck circumference (cm)
≤41  47  92.2 
>41  7.8 

BMI: body mass index.

OSAHS was confirmed in 82%; 23% were severe, 31% moderate and 45% mild (Table 2).

Table 2.

Characteristics of the patients with fibromyalgia and OSAHS.

Variable  Patients with OSAHS (+)
  FM (+)
  Mean  SD 
Age  57.57  12.33 
BMI  27.56  4.26 
  Number 
Gender
Female  33  78.60 
Male  21.40 
Severity of the OSAHS
Mild  19  45.2 
Moderate  13  31 
Severe  10  23.8 

BMI: body mass index; OSAHS: obstructive sleep apnea-hypopnea syndrome.

Discussion

A high frequency of OSAHS was found in this group of patients with FM and sleep disorders.

The prevalence of OSAHS in the general population is 10% in men aged 30-49 years, 17% in men aged 50-70 years, 3% in women aged 30-49 years and 9% in women aged 50-70 years.18

In some studies, a high frequency of coexistence of both diseases is observed. In a recent work, İnönü et al. found 12 cases of OSAHS (50%) in 24 patients with FM, while another study reported 65.9% of OSAHS in women with FM.10,19

On the other hand, when the case of patients with OSAHS was analyzed and associated FM was sought, a lower prevalence was found, as in the study conducted by Marvisi et al., in which 900 patients with OSAHS were studied and only 15% had FM.15

In the present study, the majority of patients with FM were women (82%), which is in agreement with the predominance of FM in women over men, at a ratio of 3:1.20–22

Likewise, we found that, of the 42 women studied, 78% had associated OSAHS, while in the group of men, 100% had it. This finding correlates with studies that indicate that FM can be a hidden marker of OSAHS in men.23 On the other hand, Germanowicz et al. looked for FM in patients with OSAHS and detected associated FM in 9 out of 18 women and only in 2 out of 32 men,24 so there is no clarity about the gender predominance in the association.

Meresh et al. sought the association of the 2 diseases and it was more common to find OSAHS in patients diagnosed with FM in a sleep clinic (85.8%) than in a psychiatric (42.0%), rheumatology (18.7%) or in other outpatient clinics (3.6%), which indicates a possible bias in the study of patients according to the specialty of the center that treats them.25

Some studies report unrefreshing sleep with a frequency of 70-80% in patients with FM. Being a symptom shared with OSAHS, it is interesting to search for common pathophysiological pathways between the 2 diseases to better understand the clinical behavior of both conditions.26

Since the treatment of FM represents a challenge for the clinician, the comorbidity between FM and OSAHS can make its management more complex. One study compared the clinical outcomes of patients with FM and OSAHS treated with CPAP versus patients with a single diagnosis of FM treated conventionally. The results showed that the OSAHS group had better control of symptom severity.15 According to this, the confirmation of the presence of the combination of the 2 diseases in these patients would improve their therapeutic approach.

The limitations of the study include the possible selection bias due to the fact that the characteristics of 22 patients excluded from the study for not having polysomnography are unknown, as well as the absence of a sampling process. Another limitation is that only FM patients who had a sleep complaint were referred and the rest were excluded from the study.

Multicenter prospective studies are needed to confirm these findings and investigate the response to CPAP in patients with both diseases.

Funding

The authors declare that they have not received any type of funding for the research or the preparation of the article.

Conflict of interest

None.

References
[1]
S. Moyano, J.G. Kilstein, C. Alegre de Miguel.
Nuevos criterios diagnósticos de fibromialgia: ¿vinieron para quedarse?.
Reumatol Clin, 11 (2015), pp. 210-214
[2]
D.J. Clauw, L.M. Arnold, B.H. McCarberg.
The science of fibromyalgia.
Mayo Clin Proc, 86 (2011), pp. 907-911
[3]
K. Phillips, D.J. Clauw.
Central pain mechanisms in chronic pain states - Maybe it is all in their head.
Best Pract Res Clin Rheumatol, 25 (2011), pp. 141-154
[4]
F. Wolfe, K. Ross, J. Anderson, I.J. Russell, L. Hebert.
The prevalence and characteristics of fibromyalgia in the general population.
Arthritis Rheum, 38 (1995), pp. 19-28
[5]
J. Londoño, I. Peláez Ballestas, F. Cuervo, I. Angarita, R. Giraldo, J.C. Rueda, et al.
Prevalencia de la enfermedad reumática en Colombia, según estrategia COPCORD-Asociación Colombiana de Reumatología. Estudio de prevalencia de enfermedad reumática en población colombiana mayor de 18 años.
Rev Colomb Reumatol, 25 (2018), pp. 245-256
[6]
D.L. Goldenberg.
Fibromyalgia syndrome a decade later: What have we learned?.
Arch Intern Med, 159 (1999), pp. 777-785
[7]
N. Egloff, R. von Känel, V. Müller, U.T. Egle, G. Kokinogenis, S. Lederbogen, B. Durrer, S. Stauber.
Implications of proposed fibromyalgia criteria across other functional pain syndromes.
Scand J Rheumatol, 44 (2015), pp. 416-424
[8]
F. Wolfe, D.J. Clauw, M.A. Fitzcharles, D.L. Goldenberg, R.S. Katz, P. Mease, et al.
The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity.
Arthritis Care Res (Hoboken), 62 (2010), pp. 600-610
[9]
F. Wolfe, D.J. Clauw, M. Fitzcharles, D.L. Goldenberg, W. Häuser, R.S. Katz, et al.
Fibromyalgia criteria and severity scales for clinical and epidemiological studies: A modification of the ACR preliminary diagnostic criteria for fibromyalgia.
J Rheumatol, 38 (2011), pp. 1113-1122
[10]
H. İnönü Köseoğlu, A. İnanır, S. Okan, O. Çeçen, A. Kanbay, O. Demir, et al.
Is there a link between obstructive sleep apnea syndrome and fibromyalgia syndrome?.
Turkish Thorac J, 18 (2017), pp. 40-46
[11]
B. Lario, J. Terán, J. Alonso, J. Alegre, I. Arroyo, J. Viejo.
Lack of association between fibromyalgia and sleep apnoea syndrome.
Ann Rheum Dis, 51 (1992), pp. 108-111
[12]
W. Häuser, S. Perrot, C. Sommer, Y. Shir, M.A. Fitzcharles.
Diagnostic confounders of chronic widespread pain: Not always fibromyalgia.
[13]
G. Prados, E. Miró.
Fibromialgia y sueño: una revisión.
Rev Neurol, 54 (2012), pp. 227-240
[14]
E. Aytekin, S.E. Demir, E.A. Komut, S.C. Okur, O. Burnaz, N.S. Caglar, et al.
Chronic widespread musculoskeletal pain in patients with obstructive sleep apnea syndrome and the relationship between sleep disorder and pain level, quality of life, and disability.
J Phys Ther Sci, 27 (2015), pp. 2951-2954
[15]
M. Marvisi, L. Balzarini, C. Mancini, S. Ramponi, C. Marvisi.
Fibromyalgia is frequent in obstructive sleep apnea and responds to CPAP therapy.
Eur J Intern Med, 26 (2015), pp. e49-e50
[16]
E.H.S. Choy.
The role of sleep in pain and fibromyalgia.
Nat Rev Rheumatol, 11 (2015), pp. 513-520
[17]
Sleep-related breathing disorders in adults. Recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.
Sleep, 22 (1999), pp. 667-689
[18]
P.E. Peppard, T. Young, J.H. Barnet, M. Palta, E.W. Hagen, K.M. Hla.
Increased prevalence of sleep-disordered breathing in adults.
Am J Epidemiol, 177 (2013), pp. 1006-1014
[19]
P. Mutlu, C. Zateri, A. Zohra, O. Ozerdogan, A.N. Mirici.
Prevalence of obstructive sleep apnea in female patients with fibromyalgia.
Saudi Med J, 41 (2020), pp. 740-745
[20]
M. Topbas, H. Cakirbay, H. Gulec, E. Akgol, I. Ak, G. Can.
The prevalence of fibromyalgia in women aged 20-64 in Turkey.
Scand J Rheumatol, 34 (2005), pp. 140-144
[21]
K.P. White, M. Harth.
Classification, epidemiology, and natural history of fibromyalgia.
Curr Pain Headache Rep, 5 (2001), pp. 320-329
[22]
L.P. Queiroz.
Worldwide epidemiology of fibromyalgia.
Curr Pain Headache, 17 (2013), pp. 356
[23]
K.P. May, S.G. West, M.R. Baker, D.W. Everett.
Sleep apnea in male patients with the fibromyalgia syndrome.
Am J Med, 94 (1993), pp. 505-508
[24]
D. Germanowicz, M.S. Lumertz, D. Martinez, A.F. Margarites.
Coexistência de transtornos respiratórios do sono e síndrome fibromiálgica.
J Bras Pneumol, 32 (2006), pp. 333-338
[25]
E.S. Meresh, H. Artin, C. Joyce, S. Birch, D. Daniels, J.H. Owens, et al.
Obstructive sleep apnea co-morbidity in patients with fibromyalgia: A single-center retrospective analysis and literature review.
Open Access Rheumatol Res Rev, 11 (2019), pp. 103-109
[26]
J.K. Paul, T. Iype, R. Dileep, Y. Hagiwara, J.W. Koh, U.R. Acharya.
Characterization of fibromyalgia using sleep EEG signals with nonlinear dynamical features.

Please cite this article as: Jaimes Beltrán R, Ramírez Figueroa J, Skupin Rueda NA. Comorbilidad de síndrome de apnea del sueño en pacientes con fibromialgia en una clínica de sueño. Rev Colomb Reumatol. 2022;29:177–181.

Copyright © 2021. Asociación Colombiana de Reumatología
Descargar PDF
Opciones de artículo
Quizás le interese:
10.1016/j.rcreue.2020.01.004
No mostrar más